Basic Information
| LncRNA/CircRNA Name | circCDR1as |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | nasopharyngeal cancer |
| ICD-0-3 | C11 |
| Methods | qPCR, CCK-8 and luciferase reporter assay |
| Sample | nasopharyngeal cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | The results showed that the circRNA CDR1as expression was significantly up-regulated in NPC tissues by comparison with non-tumor NPE tissues (p < 0.01), suggesting that circRNA CDR1as was associated with poor prognosis in NPC patients |
| Pubmed ID | 31582908 |
| Year | 2019 |
| Title | Circular RNA CDR1as Sponges miR-7-5p to Enhance E2F3 Stability and Promote the Growth of Nasopharyngeal Carcinoma |
External Links
| Links for circCDR1as | GenBank HGNC NONCODE |
| Links for nasopharyngeal cancer | OMIM COSMIC |